Atul Kavthekar - Dec 12, 2022 Form 4 Insider Report for P3 Health Partners Inc. (PIII)

Role
Chief Financial Officer
Signature
/s/ Jessica Puathasnanon, as attorney-in-fact
Stock symbol
PIII
Transactions as of
Dec 12, 2022
Transactions value $
$0
Form type
4
Date filed
12/14/2022, 03:16 PM
Next filing
May 16, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PIII Stock Option (Right to Buy) Award $0 +600K $0.00 600K Dec 12, 2022 Class A Common Stock 600K $3.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable with respect to 25% of the shares on December 12, 2023 (the "Initial Vesting Date"), and the remaining 75% will vest in equal annual installments over the following three years on each anniversary of the Initial Vesting Date, subject to the Reporting Person's continued service through the applicable vesting date.